Lipolysis: cellular mechanisms for lipid mobilization from fat stores
The perception that intracellular lipolysis is a straightforward process that releases fatty
acids from fat stores in adipose tissue to generate energy has experienced major revisions …
acids from fat stores in adipose tissue to generate energy has experienced major revisions …
Cytosolic lipolysis and lipophagy: two sides of the same coin
Fatty acids are the most efficient substrates for energy production in vertebrates and are
essential components of the lipids that form biological membranes. Synthesis of …
essential components of the lipids that form biological membranes. Synthesis of …
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
A Montagner, A Polizzi, E Fouché, S Ducheix, Y Lippi… - Gut, 2016 - gut.bmj.com
Objective Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor
expressed in tissues with high oxidative activity that plays a central role in metabolism. In …
expressed in tissues with high oxidative activity that plays a central role in metabolism. In …
Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics
A Yang, EP Mottillo - Biochemical Journal, 2020 - portlandpress.com
Fatty acids (FAs) are stored safely in the form of triacylglycerol (TAG) in lipid droplet (LD)
organelles by professional storage cells called adipocytes. These lipids are mobilized …
organelles by professional storage cells called adipocytes. These lipids are mobilized …
Emerging role of hepatic ketogenesis in fatty liver disease
RGR Mooli, SK Ramakrishnan - Frontiers in Physiology, 2022 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD), the most common chronic liver diseases, arise
from non-alcoholic fatty liver (NAFL) characterized by excessive fat accumulation as …
from non-alcoholic fatty liver (NAFL) characterized by excessive fat accumulation as …
Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice
M Schweiger, M Romauch, R Schreiber… - Nature …, 2017 - nature.com
Elevated circulating fatty acids (FAs) contribute to the development of obesity-associated
metabolic complications such as insulin resistance (IR) and non-alcoholic fatty liver disease …
metabolic complications such as insulin resistance (IR) and non-alcoholic fatty liver disease …
[HTML][HTML] Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)
R Schreiber, H Xie, M Schweiger - … et Biophysica Acta (BBA)-Molecular and …, 2019 - Elsevier
Adipose triglyceride lipase (ATGL) has been discovered 14 years ago and revised our view
on intracellular triglyceride (TG) mobilization–a process termed lipolysis. ATGL initiates the …
on intracellular triglyceride (TG) mobilization–a process termed lipolysis. ATGL initiates the …
[HTML][HTML] Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue
A Falkevall, A Mehlem, E Folestad, FC Ning… - Journal of …, 2023 - Elsevier
Background & Aims Hepatic steatosis is a hallmark of non-alcoholic fatty liver disease
(NAFLD), a common comorbidity in type 2 diabetes mellitus (T2DM). The pathogenesis of …
(NAFLD), a common comorbidity in type 2 diabetes mellitus (T2DM). The pathogenesis of …
A specific ChREBP and PPARα cross-talk is required for the glucose-mediated FGF21 response
A Iroz, A Montagner, F Benhamed, F Levavasseur… - Cell reports, 2017 - cell.com
While the physiological benefits of the fibroblast growth factor 21 (FGF21) hepatokine are
documented in response to fasting, little information is available on Fgf21 regulation in a …
documented in response to fasting, little information is available on Fgf21 regulation in a …
From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions
The close association of obesity with an increased risk of metabolic diseases, such as
insulin resistance, type 2 diabetes, and nonalcoholic fatty liver disease, is now well …
insulin resistance, type 2 diabetes, and nonalcoholic fatty liver disease, is now well …